Codice QR

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice

Active co-delivery of tumor antigens (Ag) and α-galactosylceramide (α-GalCer), a potent agonist for invariant Natural Killer T (iNKT) cells, to cross-priming CD8α+ dendritic cells (DCs) was previously shown to promote strong anti-tumor responses in mice. Here, we designed a nanoparticle-based vaccin...

Descrizione completa

Salvato in:
Autori principali: Jing Huang, Jing Zhou, Reem Ghinnagow, Toshiyuki Seki, Sho Iketani, Daphnée Soulard, Patrick Paczkowski, Yukiko Tsuji, Sean MacKay, Luis Javier Cruz, François Trottein, Moriya Tsuji
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020-08-01
Serie:Frontiers in Immunology
Soggetti:
nanovaccine
targeting
human CD141+ DCs
iNKT cells
α-galactosylceramide
CD8+ T cells
Accesso online:https://www.frontiersin.org/article/10.3389/fimmu.2020.02043/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi